1 recent story · Following ↗
The Joint Project Manager for Chemical, Biological, Radiological and Nuclear Medical has equipped the Joint Force with a device to counter nerve agent attacks, achieving Full Operational Capability in March 2026. The device is approved by the U.S. Food and Drug Administration. This development enhances warfighter safety and mission readiness.